BAMCO Inc’s Xenon Pharmaceuticals XENE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.45M Sell
25,000
-5,000
-17% -$230K ﹤0.01% 287
2025
Q4
$1.34M Hold
30,000
﹤0.01% 294
2025
Q3
$1.2M Sell
30,000
-26,000
-46% -$916K ﹤0.01% 296
2025
Q2
$1.75M Sell
56,000
-44,100
-44% -$1.44M ﹤0.01% 277
2025
Q1
$3.36M Hold
100,100
0.01% 269
2024
Q4
$3.92M Hold
100,100
0.01% 260
2024
Q3
$3.94M Hold
100,100
0.01% 275
2024
Q2
$3.9M Hold
100,100
0.01% 270
2024
Q1
$4.31M Hold
100,100
0.01% 276
2023
Q4
$4.61M Hold
100,100
0.01% 269
2023
Q3
$3.42M Hold
100,100
0.01% 274
2023
Q2
$3.85M Buy
100,100
+27,100
+37% +$1.08M 0.01% 275
2023
Q1
$2.61M Buy
73,000
+25,600
+54% +$946K 0.01% 286
2022
Q4
$1.87M Buy
47,400
+19,900
+72% +$725K 0.01% 314
2022
Q3
$993K Buy
27,500
+5,500
+25% +$198K ﹤0.01% 330
2022
Q2
$669K Sell
22,000
-20,000
-48% -$605K ﹤0.01% 344
2022
Q1
$1.28M Hold
42,000
﹤0.01% 348
2021
Q4
$1.31M Buy
+42,000
New +$1.26M ﹤0.01% 362

Other funds holding XENE